3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
3
Completed
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uveal Melanoma
2
Melanoma
2
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Colorectal Neoplasms
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
Gemcitabine
21
130-nm albumin-bound paclitaxel
8
irinotecan sucrosofate
7
Oxaliplatin
7
Leucovorin
7
Fluorouracil
7
Taxes
5
Drug Therapy
5
Albumin-Bound Paclitaxel
4
toripalimab
3
Specimen Handling
3
S 1 (combination)
3
Paclitaxel
3
Irinotecan
3
Injections
3
zimberelimab
2
surufatinib
2
camrelizumab
2
Pemetrexed
2
Pancreaticoduodenectomy
2
Magnetic Resonance Spectroscopy
2
Exercise
2
Capecitabine
2
Blood Specimen Collection
2
Biopsy
2
trastuzumab deruxtecan
1
sintilimab
1
semaglutide
1
potassium oxonate
1
pembrolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Pancreatic Neoplasms
×
Interleukin-2
×
Clear all
NCT05810792
2023-11-22
PANCEP-1
Sahlgrenska University Hospital
Phase 2
Not yet recruiting
50 enrolled